article thumbnail

FDA grants approval for Amylyx’s Relyvrio to treat ALS

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted approval for Amylyx Pharmaceuticals’ Relyvrio (sodium phenylbutyrate and taurursodiol) to treat adult patients with amyotrophic lateral sclerosis (ALS). The FDA approval is based on findings from the multicentre Phase II CENTAUR clinical trial that enrolled 137 ALS patients.

article thumbnail

A scientific approach to irrational consumer choices

World of DTC Marketing

GOOD MORNING: The FDA is taking a scientific approach to evaluating direct-to-consumer (DTC) drug advertising, focusing on measuring consumer perceptions of the information presented in ads. Virtually nobody will run to their doctor to ask about a drug they saw on TV without doing research first. ” Uh…no.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Fewer Prescribers Are Driving NBRx Than You Think—Here’s Why

PM360

While it’s unsurprising that patients flock to these cheaper alternatives to treat common conditions, generic medications aren’t as accessible for specialized conditions, which gives pharma marketers an opportunity to drive scripts where the market is less crowded. Symphony Health Solutions, practitioner insight’s data, 2022.

article thumbnail

FDA Approves Innovative 4D Flow MRI Blood Flow Analysis Software from Cardio Flow Design Inc.

Legacy MEDSearch

The FDA approval is significant as it recognizes the safety and effectiveness of iTFlow® in analyzing blood flow through 4D Flow MRI data, with the potential to enhance diagnostic accuracy for patients with cardiovascular diseases and heart conditions. The US Food and Drug Administration has approved the use of iTFlow® in blood flow analysis.

FDA 52
article thumbnail

Healthcare Watch September 2022

PM360

Doctor Docs: Doctors Left Concerned After Roe v. Abortion bans have made it a felony to provide or attempt to provide an abortion, meaning doctors and clinics are the ones likely to be charged and tried, rather than individual patients. FDA Update. Wade Overturn. A recent Sermo study of 240 U.S.-based Drug Approvals.

article thumbnail

Edelman Trust Barometer raises questions

World of DTC Marketing

After two years of pandemic fatigue, healthcare trust is at an all-time low, according to Edelman’s Trust Barometer Special Report on Trust in Healthcare. But do doctors trust the system? Still, the report may be too generalized for every healthcare player. Physician trust in the U.S.

article thumbnail

Pandemic Innovators: Pharma Marketing Strategies that Reinvent the In-Person Conversation

Pharmaceutical Representative Training

Before 2020, the landscape of drug marketing involved following drug approvals by the Food and Drug Administration ( FDA ), finding which patient population would benefit from therapy, and visiting specialized doctors in-person to advertise its advantages compared to current guidelines. The technology identifies.